AC699
Asset
Degrades the estrogen receptor.
- Stage
- Phase 1
- Modality
- Not known
- Target
- ESR1
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1ER-positive/HER2-negative advanced or metastatic breast cancer
Phase 1, accutarbio.com, 10 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Evidence for its targets1
- Competitors12
Every asset’s record: target, stage, trials and the evidence behind it.